Uncategorised – Page 4 – Market Industry Forecast News

Bioanalytical Testing Services Market Fueled by Increasing Focus on Biomarker Testing

The global bioanalytical testing services market was valued at USD 4.73 billion in 2024 and is anticipated to expand at a CAGR of 9.21% from 2025 to 2030. This growth is driven by the rising volume of drug development activities, increasing drug approval processes, growing therapeutic complexity, and a surge in outsourcing of testing services. The emergence of complex therapeutic modalities—such as gene therapies and biologics—has heightened the demand for specialized bioanalytical testing services. Additionally, technological advancements and rising investments in research and development are key contributors to market expansion.

The continuous evolution of advanced technologies—including High-Throughput Screening (HTS), Liquid Chromatography-Mass Spectrometry (LC-MS), and Next-Generation Sequencing (NGS)—has significantly enhanced the accuracy, speed, and sensitivity of bioanalytical testing. These innovations empower service providers to conduct more sophisticated studies and obtain precise data regarding drug efficacy, safety, pharmacokinetics, and more. Furthermore, the integration of automation and Artificial Intelligence (AI) within bioanalytical workflows has streamlined operations, minimized human error, and boosted throughput.

Moreover, heightened regulatory oversight and growing awareness of the critical role of bioanalytical testing are also fueling demand for these services. The implementation of stricter guidelines governing drug development—especially in pharmacokinetics, pharmacodynamics, and bioequivalence testing—by regulatory agencies like the U.S. FDA and EMA has led to a stronger inclination toward outsourcing. These regulations emphasize the necessity for accurate, reliable bioanalytical methods to ensure the safety and effectiveness of new drugs and biosimilars.

Pricing Analysis

The bioanalytical testing services sector utilizes various pricing models tailored to specific project requirements and levels of client engagement. Milestone-based pricing is widely adopted for projects with clearly defined stages, such as method development and sample analysis, enabling payments to be linked with the achievement of deliverables. This approach provides predictability for sponsors while aligning payments with progress for service providers. Fixed-fee pricing is more suitable for routine testing services—including bioequivalence and pharmacokinetic studies—where standardization leads to minimal variability.

Get a preview of the latest developments in the Bioanalytical Testing Services Market! Download your FREE sample PDF today and explore key data and trends

Molecule Insights

The small molecule segment held the largest market share at 55.3% in 2024. This dominance is attributed to breakthroughs in small molecule therapeutics and persistent unmet medical needs. Bioanalytical testing of small molecules plays a pivotal role in understanding their ADME (Absorption, Distribution, Metabolism, and Excretion) profiles, determining appropriate dosing, evaluating therapeutic efficacy, and ensuring patient safety.

Test Insights

In 2024, the bioavailability segment led the market. Its growth stems from its vital role in drug development and regulatory approval processes. Bioavailability studies are essential for assessing how effectively and rapidly a drug reaches systemic circulation, directly impacting dosage formulation, therapeutic efficacy, and safety. This segment is crucial for evaluating both new chemical entities and generic formulations to ensure consistent performance and compliance with bioequivalence standards.

Workflow Insights

The sample analysis segment was the dominant workflow category in 2024. This segment encompasses processes such as quantification of active pharmaceutical ingredients, metabolite detection, and stability testing—each critical for regulatory submissions and clinical trial advancement. As drug pipelines become more complex, especially with the rise of biologics and targeted therapies, demand for accurate, high-throughput sample analysis is expected to increase.

End Use Insights

In 2024, the pharma & biopharma companies segment accounted for the largest market share. This growth reflects the increasing reliance on outsourcing specialized testing throughout the drug development lifecycle. Pharmaceutical and biopharmaceutical companies are increasingly turning to external service providers to navigate the complex, highly regulated bioanalytical workflows—including pharmacokinetic assessments, immunogenicity testing, and biomarker validation. Outsourcing enables these companies to accelerate development timelines, reduce internal infrastructure costs, and access specialized expertise and advanced technologies.

Regional Insights

North America represented the largest share of the global bioanalytical testing services market, accounting for 47.40% in 2024. Growth in this region is propelled by rising demand for biopharmaceuticals, continuous technological innovation, and increased R&D investment in novel drug development. Advancements in mass spectrometry, chromatography, and other analytical techniques have further improved the sensitivity, specificity, and throughput of bioanalytical testing. These innovations enable laboratories to conduct more precise and efficient analyses, supporting faster drug development timelines and lowering costs.

Leading Companies in the Bioanalytical Testing Services Market

The following companies are key players in the bioanalytical testing services market, collectively holding a significant share and shaping industry trends:

Thermo Fisher Scientific Inc.
ICON Plc
Charles River Laboratories International
IQVIA Inc.
Syneos Health
SGS SA
Labcorp
Intertek Group Plc
Pace Analytical Services LLC
WuXi AppTec

Gather more insights about the market drivers, restrains and growth of the Bioanalytical Testing Services Market

U.S. Steel Rebar Market Benefits from Advancements in Reinforcement Technology

The U.S. steel rebar market was valued at USD 6.50 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 5.2% from 2025 to 2030. This growth is primarily driven by increased investments in residential development projects across the U.S.

The rising demand for affordable housing has prompted state and local governments to allocate more funds for affordable housing initiatives. For example, in October 2024, the U.S. Department of the Treasury announced USD 246.4 million in funding for the development of affordable housing and community infrastructure aimed at low-income communities and families.

Pricing Trends
Steel rebar prices in the U.S. have experienced notable fluctuations in recent years, influenced by supply chain disruptions, raw material prices, and global demand. In 2021, prices soared to approximately USD 1,000 per ton due to pandemic-related shortages and an uptick in construction activity, a significant jump from the pre-pandemic price of around USD 600 per ton. By mid-2023, prices began to stabilize at around USD 800 per ton, though still above historical norms. The volatility in scrap metal prices, a critical input for rebar, continues to affect market pricing.

Application Insights
The growth of public construction is expected to further drive market expansion during the forecast period. For instance, the value of public construction in the U.S. reached USD 489,772 million in August 2024, up from USD 454,126 million in August 2023, marking a year-on-year increase of 7.8%.

The infrastructure segment is anticipated to witness the fastest revenue growth, with a projected CAGR of 5.6% over the forecast period. Increasing investments by state governments in infrastructure development are expected to propel steel rebar consumption.

The Infrastructure Investment and Jobs Act (IIJA) is also contributing to higher rebar demand, with $110 billion allocated for roads and bridges. Projects such as the Interstate Bridge Replacement and the repair of aging highways are driving the need for steel rebar. Furthermore, new innovations in high-strength and corrosion-resistant rebar are being used in coastal and high-moisture areas, where traditional materials would deteriorate faster, extending the lifespan of infrastructure.

The industrial segment is another important application for steel rebar, particularly in the construction of industrial facilities like processing plants, mining structures, factories, and warehouses. Increased investment in new industrial facilities is expected to boost demand for rebar in the coming years.

Get a preview of the latest developments in the U.S. Steel Rebar Market! Download your FREE sample PDF today and explore key data and trends

Regional Insights
Northeast U.S. Steel Rebar Market Trends
In the Northeast U.S., the demand for steel rebar is primarily driven by urban infrastructure needs, especially in high-density areas such as New York City and Boston. Ongoing investments in bridge repairs and subway expansions have made this region responsible for approximately 17.7% of the nation’s rebar consumption by volume in 2024. The demand for corrosion-resistant rebar is especially high due to the coastal environment, which accelerates wear in traditional steel applications.

Key U.S. Steel Rebar Company Insights
Prominent companies operating in the U.S. steel rebar market include CMC Steel, Nucor, and Steel Dynamics, Inc.

Commercial Metals Company (CMC) is a leading manufacturer and recycler of steel and metal products, headquartered in Irving, Texas. It operates a network of mini-mills, fabrication facilities, and recycling centers across the U.S. and Europe, specializing in rebar, steel wire, and other long steel products.
Steel Dynamics, Inc. (SDI) is one of the largest steel manufacturers and metal recyclers in the U.S., with operations in flat-rolled steel, structural steel, and rebar production. SDI is known for its innovative steelmaking processes and integrating recycling into its operations.

Key U.S. Steel Rebar Companies:

Acerinox S.A
ArcelorMittal
CMC Steel
EVRAZ U.S., Inc.
Gerdau S.A
Liberty Steel USA
Nucor
Outokumpu
Schnitzer Steel Industries, Inc.
Steel Dynamics, Inc.

Gather more insights about the market drivers, restrains and growth of the U.S. Steel Rebar Market

Pathology Laboratories Market Gains Momentum with Increasing Cancer Screening

The global pathology laboratories market was valued at USD 386.18 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.1% from 2025 to 2030. This growth is primarily fueled by the expansion of healthcare facilities in developing regions, rising demand for routine medical examinations, and improvements in reimbursement policies for diagnostic tests. Additional drivers include an aging global population and the increasing prevalence of chronic diseases. Moreover, the market is benefiting from the establishment of new laboratories in emerging markets. For example, in August 2024, Neuberg Diagnostics launched a new laboratory facility in Puducherry, India, offering radiology, wellness, and pathology services.

As chronic diseases become more widespread, the demand for robust healthcare systems and timely diagnostics continues to rise. Early and accurate diagnosis is essential for effective management of chronic conditions, leading to greater reliance on clinical diagnostics. According to the World Health Organization, the global senior population is expected to increase from 1 billion in 2020 to 1.5 billion by 2030, with one in six people worldwide aged 60 or older. Chronic illnesses are especially common among older adults; the National Council on Aging reports that 80% of U.S. adults aged 65 and above have at least one chronic condition, emphasizing the critical need for regular health screenings in this age group.

The trend toward routine health check-ups is also on the rise. Given the high incidence of chronic conditions, individuals over 40 are strongly encouraged to undergo regular health screenings. Meanwhile, the growing occurrence of chronic diseases among younger adults has led to increased demand for preventive check-ups within this demographic. Heightened health awareness has motivated more individuals to prioritize routine medical evaluations.

In addition, many countries require employers to provide annual health assessments for their employees, creating further demand for diagnostic laboratory services. Increased healthcare spending aimed at improving infrastructure in developing nations has also contributed to the establishment of new hospitals and diagnostic labs, along with upgrades to existing facilities. For instance, in March 2022, the Delhi government announced plans to upgrade 15 hospitals and build four new hospitals in the city, boosting the expansion of hospital-based diagnostic centers.

Type Insights
In 2024, the hospital-based segment led the market, accounting for 55.7% of total revenue. The growth of hospital-based laboratories is driven by several factors: the rising burden of chronic diseases necessitating prompt and accurate diagnostics; technological advancements that enhance testing efficiency and accuracy; and the growing emphasis on patient-centered care, encouraging integration of laboratory services with clinical operations to improve outcomes. Furthermore, favorable reimbursement policies and the increasing demand for routine health screenings continue to support the expansion of hospital-based labs within healthcare systems.

Testing Services Insights
The general physiological and clinical tests segment held the largest market share in 2024, representing 39.2% of the total. These tests—including blood counts, metabolic panels, and urinalysis—are fundamental tools for diagnosing diverse health conditions and monitoring patient health. Their broad use across primary care, outpatient clinics, and hospitals sustains steady demand, as they are vital for early disease detection and effective treatment planning.

Get a preview of the latest developments in the Global Pathology Laboratories Market! Download your FREE sample PDF today and explore key data and trends

End-use Insights
In 2024, physician referrals accounted for 51.7% of the overall market share. Approximately 70% of physicians’ medical decisions depend on diagnostic and pathological test results, underscoring the critical role of laboratory testing in clinical decision-making. The increasing prevalence of targeted diseases across various age groups is expected to further drive the growth of this segment.

Regional Insights
North America dominated the global pathology laboratories market in 2024, capturing a 37.87% revenue share. The region’s leadership is attributed to its advanced healthcare infrastructure, high adoption of innovative diagnostic technologies, and well-established regulatory environment. Additionally, rising rates of chronic diseases, growing demand for personalized medicine, and increasing healthcare expenditures contribute to North America’s prominent position in the global market.

Key Pathology Laboratories Companies
The leading companies shaping the pathology laboratories market include:

Quest Diagnostics Incorporated
Eurofins Scientific
Laboratory Corporation of America Holdings
Exact Sciences Laboratories LLC
Spectra Laboratories
SYNLAB International GmbH
Sonic Healthcare Limited
Dr. Lal Path Labs
Metropolis Healthcare
Kingmed Diagnostics
Healius Limited
BioReference
Centro de Diagnósticos
Falco Holdings
Unilabs

Gather more insights about the market drivers, restrains and growth of the Pathology Laboratories Market

Medical Equipment Maintenance Market Driven by Strict Regulatory Compliance Needs

The global medical equipment maintenance market was valued at USD 41.90 billion in 2023 and is projected to expand at a CAGR of 10.0% from 2024 to 2030. The market’s growth is driven by the rising global demand for medical devices, the increasing prevalence of life-threatening conditions requiring diagnostic procedures, and the growing need for refurbished medical equipment.

Given the critical role of medical equipment in healthcare delivery, the effectiveness of treatments largely depends on the precision and performance of these devices. A wide range of equipment—such as electrocardiographs, syringe pumps, centrifuges, X-ray machines, autoclaves, and ultrasound devices—are used across healthcare settings for diagnosis and treatment. Due to continuous use, these devices require regular maintenance to address wear, malfunctions, and potential defects.

In 2023, imaging equipment led the market, accounting for 36.1% of total market share. Imaging devices are essential for visualizing internal body structures and facilitating accurate diagnosis. The rising incidence of chronic conditions, particularly cardiovascular diseases, is fueling demand in this segment. According to the Centers for Disease Control and Prevention, approximately 129 million people in the U.S. suffer from at least one major chronic disease. Common imaging modalities include X-rays, magnetic resonance imaging (MRI), computed tomography (CT) scans, and ultrasound.

Service Insights

The corrective maintenance segment held the largest revenue share in 2023. This segment focuses on repairing equipment following malfunctions or failures, restoring systems to their original working condition through replacement or restoration efforts. The increasing frequency of equipment breakdowns—stemming from constant use in modern healthcare facilities—is expected to drive rapid growth in this area.

Service Provider Insights

In 2023, the Original Equipment Manufacturer (OEM) segment captured the highest revenue share. OEMs provide highly specialized maintenance services tailored to their products, leveraging their deep understanding of the equipment’s design, components, and functionality. By offering post-warranty maintenance and repair services, OEMs not only generate additional revenue but also strengthen long-term relationships and foster customer loyalty.

Get a preview of the latest developments in the Global Medical Equipment Maintenance Market! Download your FREE sample PDF today and explore key data and trends

End-Use Insights

The hospital segment accounted for the largest revenue share in 2023. An aging global population is contributing to a rise in chronic diseases such as diabetes, heart disease, and cancer, driving the need for advanced diagnostic and therapeutic equipment. Private hospitals are investing in state-of-the-art devices to enhance patient care and attract more patients. Additionally, increased government spending on healthcare infrastructure continues to bolster the demand for sophisticated medical equipment.

Regional Insights

In 2023, North America dominated the global medical equipment maintenance market. Factors such as advancements in medical infrastructure, a growing burden of chronic illnesses, increased healthcare spending, and the presence of ambulatory surgical centers are fueling market growth in the region. North America’s strong healthcare sector and its growing role in medical tourism have sustained demand for reliable, fully operational medical equipment.

Leading Companies in the Medical Equipment Maintenance Market

The key players shaping the medical equipment maintenance market include:

GE HealthCare
Siemens Healthineers AG
Medtronic
Aramark
Koninklijke Philips N.V.
B. Braun SE
AlphaSource Group
Althea Group

Gather more insights about the market drivers, restrains and growth of the Medical Equipment Maintenance Market

Athletic Footwear Market Supported by Growth in Women’s Sports Participation

The global athletic footwear market was valued at USD 127.3 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 4.9% between 2022 and 2030. This growth is being driven by increasing interest in fitness and sports activities, the rapid expansion of the global retail e-commerce sector, and rising disposable incomes. A growing number of young individuals are embracing healthier lifestyles and actively participating in various sports and fitness pursuits. Moreover, the general public is becoming more aware of the role physical activity plays in promoting good health and reducing risks associated with chronic conditions such as depression, cardiovascular diseases, and diabetes.

The COVID-19 pandemic had a notable impact on athletic footwear and activewear sales in the U.S. In terms of brand performance, Nike footwear sales dropped in the high teens, Brand Jordan declined in the low teens, and Converse sales plummeted by over 30%. Brands like Adidas, Skechers, ASICS, and Vans experienced sales decreases in the teens, Under Armour declined around 25%, and Fila saw nearly a 50% drop.

Certain product categories were especially affected, particularly those associated with spring sports, which faced widespread cancellations or postponements. Sales of baseball, soccer, and golf shoes fell by an average of 30%. Performance basketball and sports lifestyle footwear saw mid-teen declines, as did running shoes. Skateboarding shoes, which had been gaining momentum before the pandemic, also faced significant setbacks. However, there were some positive notes: Brooks achieved a mid-single-digit growth, while Puma experienced a modest increase in the low single digits.

Consumers are increasingly prioritizing the use of appropriate footwear for different types of sports to help prevent injuries such as muscle strains, knee pain, hip issues, and back discomfort. As a result, the demand for athletic shoes is anticipated to rise significantly in the coming years. The appeal of athletic footwear spans a wide user base, including athletes, climbers, fitness enthusiasts, and individuals who engage in light workout routines. These products are made from high-quality materials such as leather, foam, and plastic, enhanced with advanced chemical components.

Environmental concerns are posing challenges to the industry’s growth. Regulatory actions and environmental advocacy groups are putting pressure on manufacturers to curb pollution. Industrial processes, especially in footwear manufacturing, have been cited as major contributors to environmental degradation. For instance, Greenpeace’s “Dirty Laundry” report called out brands like Puma, Nike, and Adidas for allegedly working with suppliers in China whose practices were linked to pollution of the Yangtze and Pearl Rivers.

To stay ahead, major market players such as Nike, Inc., Adidas AG, Skechers USA, Inc., and New Balance Athletics, Inc. are investing in technological innovations aimed at enhancing shoe comfort and stability. For example, Adidas AG developed Forged Mesh — a single-layer upper with a ribbed pattern, designed using ARAMIS motion capture technology to analyze foot strain. This innovation provides greater flexibility and support around the ankle. Other notable Adidas technologies include Adaptive Traxion, Boost, Bounce, Climachill, Promeknit, and Stableframe.

Get a preview of the latest developments in the Global Athletic Footwear Market! Download your FREE sample PDF today and explore key data and trends

Regional Insights
Asia Pacific led the global market in 2021, accounting for over 35.0% of total revenue. The region is expected to maintain this leadership position throughout the forecast period. Key factors contributing to this growth include rising disposable incomes and the increasing reach of e-commerce. The region’s growing interest in sports events such as the Asian Games, ICC Cricket World Cup, and ACC Asia Cup also fuels demand for athletic footwear.

In 2017, Asia Pacific recorded the highest shipment volumes—around 260 million units—and is projected to retain its lead through 2025. This is primarily due to its large population and more affordable pricing of athletic shoes compared to developed regions like the U.S. and U.K. In North America, the U.S. is a major revenue contributor, driven by a strong culture around fitness, sports, and outdoor activities such as aerobics, trail running, and hiking.

Key Companies & Market Share Insights
The global market comprises both global and local players, many of whom are focusing on innovation and new product introductions. For instance, in March 2021, Adidas launched the Yeezy 450 series — a continuation of the Yeezy 350 line inspired by Kanye West. In June 2021, the ASICS GEL-Quantum Levitrack, designed by Kiko Kostadinov, was introduced, featuring a GEL midsole for enhanced performance. Prominent companies in the global athletic footwear market include:

Adidas AG
ASICS Corporation
Fila Inc.
Under Armour, Inc.
Lotto Sport Italia S.p.A
New Balance Athletics, Inc.
Vans, Inc.
Nike, Inc.
Puma SE
Reebok International Ltd.

Gather more insights about the market drivers, restrains and growth of the Athletic Footwear Market

Handbag Market Strengthens with Innovation in Smart and Tech-Enabled Bags

The global handbag market was valued at USD 73.32 billion in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 6.8% between 2023 and 2030. Over the years, there has been a notable increase in female participation in the global workforce. Women now play key roles across a variety of industries, ranging from leadership positions in corporate sectors to entrepreneurial ventures. This shift has fueled demand for accessories that cater to the dynamic needs of professional women. As a result, handbags have transitioned from being merely fashion items to becoming indispensable tools that support the complexities of modern work life.

Today’s working women prioritize both function and fashion, making handbags essential in their daily lives. These bags allow seamless movement between professional and personal spheres, accommodating work-related necessities like laptops, planners, and documents, alongside personal items such as wallets, cosmetics, and tech gadgets. According to a June 2023 Omnibus survey by Circana, 39% of American women aged 18 to 34 carry a handbag to their workplace or educational institution. Additionally, more than 60% of women aged 35 and above consistently carry handbags beyond work or school contexts.

The growing reliance on handbags among professional women is a key market trend. Supporting this, data from the U.S. Bureau of Labor Statistics released in April 2021 revealed that women held 57.4% of U.S. jobs in 2019, up from 57.1% in 2018. The increase in female workforce participation significantly contributes to handbag market growth, particularly in the United States. Moreover, the expansion of corporate and organized sectors has amplified the product’s demand across the country.

Get a preview of the latest developments in the Global Handbag Market! Download your FREE sample PDF today and explore key data and trends

A survey conducted by The International Council of Societies of Industrial Design (ICSID) in November 2021 found that the average American woman owns 11 handbags and typically spends around USD 160 on each. Such high consumer spending supports the handbag market’s robust growth in the United States, solidifying its position as the leading regional market.

Luxury and premium handbags have increasingly become symbols of personal identity and status, extending beyond mere functionality. Rising disposable incomes—especially in developing regions—paired with aspirational buying behavior, are driving consumer interest in high-end handbag products. Alongside established luxury labels, emerging designers and niche brands are entering the market with unique styles and artisanal quality, appealing to consumers seeking distinctiveness and exclusivity, thereby enhancing the diversity of the luxury handbag sector.

Regional Insights
In 2022, Asia Pacific led the global handbag market, accounting for a 37.30% share of total revenue. The region’s growing purchasing power and the proliferation of e-commerce platforms have significantly boosted handbag demand. Increasing fashion awareness and consumer spending on accessories have also played crucial roles in market expansion. For instance, Net-a-Porter reported in May 2020 that handbag sales in the Asia Pacific region surged by 261% compared to 2019.

China, in particular, has witnessed remarkable economic growth and a surge in household consumption of consumer goods over the past decade. The rising demand for luxury products in China is expected to continue driving handbag sales.

Key Market Players
Major companies operating in the global handbag market include:

Louis Vuitton
Hermès International S.A.
Michael Kors
Fossil Group, Inc.
Guccio Gucci S.p.A.
Prada S.p.A.
Burberry Group Plc
Tapestry, Inc.
Chanel
Compagnie Financière Richemont SA

Gather more insights about the market drivers, restrains and growth of the Handbag Market

Disposable Gloves Market Fueled by Rising Demand in Pharmaceuticals and Laboratories

The global disposable gloves market was valued at USD 12.71 billion in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 8.5% from 2025 to 2030. Growth in the global disposable gloves industry is anticipated due to multiple factors, including supportive occupational safety regulations, heightened focus on workplace safety, and increased healthcare spending. Developing economies are projected to see significant growth in their healthcare sectors, driven by rising investments in both public and private domains, growing populations, an influx of migrants, and an expanding elderly demographic. Additionally, increased healthcare expenditure is expected to propel the growth of the healthcare industry, consequently boosting the demand for disposable gloves.

Market growth is further supported by the presence of advanced healthcare infrastructure, greater disposable income among patients, and a notable elderly population. Industries such as healthcare, medical, and mining expose workers to hazardous chemicals, which can lead to skin conditions, rashes, cuts, amputations, and contact with bloodborne pathogens. The enforcement of stringent safety regulations is likely to play a key role in expanding market demand.

There is a rising emphasis on the quality of raw materials used in disposable gloves, focusing on attributes such as heat resistance, comfort, elasticity, and lightweight design. This awareness is expected to drive innovation and research efforts among key market players, aiming to improve glove performance and broaden their applications through enhanced product design.

Regional Overview
North America led the global disposable gloves market, accounting for 36.7% of the global share in 2024. This dominance is attributed to increasing hygiene awareness, particularly in healthcare environments in the wake of the COVID-19 pandemic. Additionally, growing demand from the food and manufacturing sectors, coupled with government-mandated personal protective equipment (PPE) requirements, has supported regional market expansion. The preference for high-quality nitrile gloves—known for their strength and chemical resistance—continues to grow in North America. Manufacturers are also ramping up local production to mitigate supply chain disruptions.

Get a preview of the latest developments in the Global Disposable Gloves Market! Download your FREE sample PDF today and explore key data and trends

Leading Companies in the Disposable Gloves Industry
Prominent players in the disposable gloves market include Top Glove Corporation Bhd, Hartalega Holdings Berhad, Ansell Ltd, and Kossan Rubber Industries Bhd.

Top Glove is a global leader in rubber glove manufacturing, offering latex, nitrile, and vinyl gloves across healthcare, food, and industrial sectors.
Hartalega focuses on nitrile glove production and is known for its commitment to innovation and advanced technology, serving both healthcare and laboratory environments.
Supermax Corporation Berhad, Kossan Rubber Industries Bhd, and Kimberly-Clark Corporation are also notable participants in the evolving market.
- Kossan Rubber Industries, based in Malaysia, manufactures a range of rubber products, including gloves for medical and non-medical use, emphasizing quality and innovation.
- Kimberly-Clark, a multinational company based in the U.S., offers a variety of disposable gloves under its healthcare and industrial brands.

Key Disposable Gloves Companies:
These leading companies shape the direction of the market and hold significant market shares:

Ansell Ltd
Top Glove Corporation Bhd
Hartalega Holdings Berhad
Supermax Corporation Berhad
Kossan Rubber Industries Bhd
Ammex Corporation
Kimberly-Clark Corporation
Sempermed USA, Inc
MCR Safety

Gather more insights about the market drivers, restrains and growth of the Disposable Gloves Market

Brain Health Supplements Market Trends Reflect Shift Toward Preventive Healthcare

The global brain health supplements market reached a valuation of USD 8.63 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 13.3% from 2023 to 2030. This growth is largely driven by increasing awareness around mental health concerns, including attention deficits, memory decline, anxiety, and depression. Additionally, a rising preference for natural and herbal health remedies is expected to further propel market expansion during the forecast period. The growing demand for multifunctional supplements that act as energy boosters, antidepressants, cognitive enhancers, and anxiety relievers is likely to stimulate more research and development in this space. Furthermore, heightened interest from the sports industry in improving cognitive performance among athletes is anticipated to create new growth opportunities.

Individuals involved in academic and professional settings are expected to significantly contribute to the rising demand for brain health supplements in the coming years. These products are also expected to gain traction among people dealing with various neurological conditions such as depression, dementia, anxiety, and insomnia.

A report by the World Health Organization (WHO) published in September 2021 highlighted that approximately 280 million people worldwide of all age groups suffer from depression. In the United States, anxiety disorder is one of the most prevalent mental health conditions.

According to an October 2022 report by the Anxiety & Depression Association of America, about 19.1% of U.S. adults—equivalent to 40 million individuals—experience anxiety. As awareness of mental health issues continues to grow, the application scope for brain health supplements is expected to broaden accordingly.

These supplements are also being used to manage other cognitive and age-associated conditions, including hyperactivity and Parkinson’s disease. Growing concern about mental wellness and cognitive health is anticipated to support continued market growth.

Memory-enhancing brain supplements recorded the highest market penetration in 2022. Heightened competition in both educational and professional environments has fueled demand for these products. Moreover, the increasing need to support memory retention among aging populations has further boosted market interest.

Consumers are also drawn to these supplements due to their affordability and ease of access, which are expected to continue driving product adoption and segment growth.

Initially focused on aging baby boomers aiming to delay or prevent cognitive decline, cognitive enhancement supplements are now also being marketed toward millennials, a generation frequently seeking productivity-boosting solutions under high-pressure conditions.

Get a preview of the latest developments in the Global Brain Health Supplements Market! Download your FREE sample PDF today and explore key data and trends

Regional Insights
North America led the global market in 2022, accounting for over 40.1% of the total share. Demand in the region has seen notable growth, spurred by increasing health consciousness and rising interest in cognitive wellness products, particularly among younger consumers.

A survey by the American Association of Retired Persons (AARP) in June 2019 revealed that a large segment of Americans aged 50 and older regularly consume brain health supplements, primarily driven by concerns over cognitive decline and brain health.

Meanwhile, the Asia Pacific region is projected to experience the fastest growth, with a CAGR of 15.8% from 2023 to 2030. This surge is attributed to heightened awareness of supplement benefits, a preference for natural over pharmaceutical options, and a growing incidence of Alzheimer’s in countries like China, India, and Japan.

Key Players in the Global Brain Health Supplements Market Include:

Natural Factors Nutritional Products Ltd
Onnit Labs, Inc.
Purelife Bioscience Co., Ltd
Intelligent Labs
Accelerated Intelligence Inc.
NOW Foods
HVMN Inc.
Teva Pharmaceutical Industries Ltd.
Peak Nootropics
Alternascript

Gather more insights about the market drivers, restrains and growth of the Brain Health Supplements Market

Gene Therapy Market Propelled by Innovation in Viral and Non-Viral Vectors

The global gene therapy market was valued at USD 5.54 billion in 2023 and is anticipated to expand at a compound annual growth rate (CAGR) of 18.88% from 2024 to 2030. This growth is driven by several key factors, including the rising advancement in therapeutic technologies and gene delivery methods, as well as intensifying competition among major industry players aiming to commercialize their therapies. Biotechnology firms are actively pursuing mergers, acquisitions, collaborations, and strategic partnerships to build internal expertise and strengthen their product pipelines.

The COVID-19 pandemic had an adverse impact on market performance. The industry faced significant disruptions in supply chains, production capabilities, and logistics operations. For example, certain companies experienced prolonged delays in obtaining specific components and later encountered shortages in clinical trial supplies after one of their contract manufacturing partners was forced to cease operations.

Despite this, the market is expected to gain momentum in the coming years, supported by a strong development pipeline. Researchers are striving to bring gene therapy into routine clinical practice. Numerous academic institutions and research centers have an extensive range of products under development, which is projected to contribute to revenue growth throughout the forecast period. Notably, clinical trials for gene therapy surged following the FDA’s approval of the first gene therapy in 2017. According to the American Society of Gene & Cell Therapy (ASGCT), there are currently approximately 1,986 gene therapy-related products in development, including CAR T-cell therapies and other genetically engineered cell treatments.

In addition, evolving regulatory frameworks are expected to foster further growth. Several global regulatory agencies have implemented positive changes to facilitate the advancement of gene therapies. For instance, the FDA has expressed strong support for CAR-T cell technology. During Phase II and III clinical studies, regulators are showing increased flexibility in the traditional trial structure. The FDA anticipates approving between 10 and 20 new gene therapies annually by 2025.

Increased funding and investment in gene therapy is also projected to offer promising growth prospects for industry players. Many biopharmaceutical companies are channeling resources into the development of new products. For example, Ori Biotech secured over USD 100.0 million in Series B funding in January 2022 to launch an innovative platform for cell and gene therapy development, enabling a swift progression from pre-commercialization to full market entry.

Get a preview of the latest developments in the Global Gene Therapy Market! Download your FREE sample PDF today and explore key data and trends

Regional Overview
In 2023, North America led the global gene therapy market, capturing a revenue share of 18.95%. This dominance is expected to continue throughout the forecast period, both in terms of regulatory approvals and revenue generation. Strong investment in research and development by both established and emerging companies is anticipated to drive further market expansion in the region.

Leading Companies in the Gene Therapy Market:
The key players shaping the gene therapy landscape and holding significant market shares include:

Amgen Inc.
Novartis AG
F. Hoffmann-La Roche
Gilead Sciences, Inc.
bluebird bio, Inc.
Bristol-Myers Squibb Company
Legend Biotech
BioMarin
uniQure N.V.
Merck & Co.
Sarepta Therapeutics, Inc.
Krystal Biotech, Inc.
CRISPR Therapeutics

Gather more insights about the market drivers, restrains and growth of the Gene Therapy Market

Iron and Steel Market Strengthens with Increased Production Capacity and Exports

The global iron and steel market was valued at USD 1,676.24 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 3.8% between 2023 and 2030. The anticipated growth is primarily driven by increasing investments in residential construction. Iron and steel products offer a high strength-to-weight ratio, enabling them to withstand substantial loads and resist compression, tension, and bending forces. These attributes make them particularly suitable for supporting tall structures and efficiently distributing weight to the foundation. Additionally, these materials exhibit excellent durability and resistance to corrosion, weather effects, and pests, contributing to the long-term structural integrity of buildings and reducing ongoing maintenance costs—making them a preferred option in the construction sector.

In North America, the United States stands out as a major consumer of iron and steel, owing to heightened demand from key sectors such as construction, infrastructure, automotive, transportation, heavy machinery, and consumer goods. As per the U.S. Census Bureau, total construction expenditure in the country for the first five months of 2023 reached USD 740.8 billion, marking an increase of approximately 2.9% compared to the same period in 2022.

Government initiatives are also anticipated to stimulate demand for domestic iron and steel products. For example, in April 2022, the U.S. government mandated that all iron and steel used in federally funded infrastructure projects under the Job’s Act must be domestically produced. This regulation requires all stages of production, including melting and coating, to be conducted within the United States.

Additionally, increasing demand for heavy machinery is expected to further support product consumption throughout the forecast period. For instance, in May 2023, new orders for manufactured durable goods rose by 1.7%, with transportation equipment orders seeing a 3.9% increase compared to April 2023.

The ongoing Russia-Ukraine conflict has had a negative impact on the iron and steel industry, resulting in significant price hikes. According to the United Nations Conference on Trade and Development, the disruption in the supply of oil, gas, and coking coal from Russia has contributed to a notable rise in global energy prices, which in turn has led to a reduction in the consumption of various iron and steel products across multiple end-use industries.

Get a preview of the latest developments in the Global Iron And Steel Market! Download your FREE sample PDF today and explore key data and trends

Regional Insights
In 2022, the Asia Pacific region accounted for more than 59.0% of the global iron and steel market’s revenue. This dominance is attributed to rising investments in the residential and commercial construction sectors in emerging economies such as China and India. For example, TARC Limited announced a planned investment of INR 250 crore (USD 30.23 million) in 2022 to develop a luxury residential project in New Delhi, India.

North America is expected to post a revenue CAGR of 4.2% during the forecast period. Growing investments in electric vehicle production are projected to boost the demand for iron powder, electric steel, and other related components in the coming years.

Key Companies & Market Share Insights
The market is composed of numerous players, both large and small, operating globally. Many of these companies are pursuing expansion through strategic acquisitions and capacity enhancements. For example, in January 2022, Steel Dynamics acquired a 45% equity interest in New Process Steel. This move is expected to broaden Steel Dynamics’ involvement in value-added manufacturing opportunities. Leading companies in the global iron and steel market include:

Arcelor Mittal S.A.
China BaoWu Steel Group Corporation Limited
Nippon Steel Corporation
HBIS Group
Jiangsu Shagang Group
POSCO HOLDINGS INC.
Tata Steel Limited
JFE Steel Corporation
Shougang Group

Gather more insights about the market drivers, restrains and growth of the Iron And Steel Market